Skip to contentClarengateINTELLIGENCE
Companies/13237941

Mitorx Therapeutics Limited

Research and experimental development on biotechnology · Oxford

ActiveUnited KingdomIncorporated 2021Private Limited Company
Register Ask analyst

Financial position

Accounts to 2025-03-31 · GBP · Company accounts

Net assets
£1,396,954
Cash
£1,123,795
Turnover
—
Profit / loss
—
Current assets
£1,426,654
Creditors < 1 year
£216,690
Equity
£1,396,954
Average employees
9

Balance-sheet trend

GBP · company

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

5 periods
Reported figures2025-03-31Company2024-03-31Company2023-03-312022-03-312021-03-01
Balance sheet
Net assets£1,396,954£1,470,387£2,109,202£1,348,943—
Equity£1,396,954£1,470,387£2,109,202£1,348,943—
Assets
Fixed assets£186,990£76,939£20,963£2,259—
Intangible assets£69,895£44,362£9,295£0—
Property, plant & equipment£117,095£32,577£11,668£2,259—
Current assets£1,426,654£1,585,233£2,259,460£1,386,027—
Cash at bank£1,123,795£1,249,318£1,841,161£1,319,267—
Liabilities
Creditors within one year£216,690£191,785£171,221£39,343—
Net current assets£1,209,964£1,393,448£2,088,239£1,346,684—
Assets less current liabilities£1,396,954£1,470,387£2,109,202£1,348,943—
People
Average employees99740
Source evidenceView filing View filing View filing View filing View filing

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

0 outstanding charges
Show 1 satisfied / released
Fixed · created 2021-11-18 · satisfied 2022-02-14
—
Satisfied